Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures

Month: March 2023

Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures

Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties.

The full article can be read and downloaded here

Please contact us via info@rheavita.com if you wish to learn more about how continuous freeze-drying enables the stabilization of your mRNA therapy for distribution and storage.

For formulation development, the freeze-drying process development, and production, we can be your partner in getting your therapy fast to the market with the highest quality while avoiding cold chain logistics.

For the most up to date news, please follow us on LinkedIn via the link below

LinkedIn

Advanced Therapies - March 14 - 15, 2023

Month: March 2023

Presented poster on freeze-drying as a gene therapy stabilizer

On March 14 & 15 we attended the Advanced Therapies Congress in London where we presented a new poster on avoiding cold chain logistic challenges by using freeze-drying to stabilize gene therapies. The poster can be viewed here.

Reach out to us via info@rheavita.com if you wish to book a meeting or would like to learn more about freeze-drying of gene therapies or other ATMPs.

More info on the event can be found here: Advanced Therapies

For the most up to date news, please follow us on LinkedIn via the link below

LinkedIn

New poster publications available

Month: March 2023

2 new poster publications are available

Implementing PAT for real-time product monitoring and control during continuous freeze-drying can be read and downloaded here

Avoiding cold chain logistics can be read and downloaded here

For the most up to date news, please follow us on LinkedIn via the link below

LinkedIn

CCP Summit - March 7 - 9, 2023

Month: March 2023

See our poster on the benefits of PAT during continuous freeze-drying

RheaVita will participate in the 7th Commercializing Continuous Processing in Pharma Summit in Boston. There we will present a poster on “Implementing PAT during continuous freeze-drying allows real-time monitoring and control of relevant Critical Quality Attributes providing the potential for real-time release.”

The conference will take place in Boston from March 7 to 9, 2023.

More info can be found here.

For the most up to date news, please follow us on LinkedIn via the link below

LinkedIn